Literature DB >> 214304

Accumulation of 99m Tc-Sn-pyrophosphate in pleural effusions.

C Aprile, G Bernardo, M Carena, A Favino, G R Cuna, M R Strada, S Mascherpa.   

Abstract

Accumulation of 99m Tc-Sn-pyrophosphate in pleural effusions has been evaluated in 56 patients grouped as follows: 8 with bacterial effusion (Group A), 27 with malignant effusion treated by local and/or parenteral antitumor chemotherapy (Group B), 21 with malignant effusion treated only by supportive therapy (Group C). Results, expressed as effusion to plasma PPi ratio, ranged from 0.1 to 0.28 in group A, from 0.04 to 0.64 in group B and from 0.60 to 1.73 in group C, with significant differences among the three groups. In no case was uptake found in cells of the sediment. Chemical analysis (including total and ionized calcium, total protein, acid and alkaline phosphatase) of plasma and exudate in neoplastic patients showed a slight, but significant, difference between groups B and C as regards plasma-effusion gradient for total calcium and acid phosphatase. Negative correlation also exists between effusion to plasma PPi ratio and plasma-exudate gradient for ionized calcium in neoplastic patients. The data support the hypothesis that acid phosphatase content and calcium gradient are among the factors involved in the mechanism of PPi accumulation in pleural effusions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214304     DOI: 10.1007/bf00251395

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  8 in total

1.  Accumulation of 99mTc-diphosphonate in malignant pleural effusions: detection and verification.

Authors:  M E Siegel; W J Walker; J L Campbell
Journal:  J Nucl Med       Date:  1975-10       Impact factor: 10.057

2.  Letter: Some differences between 87mSr and 99mTc-polyphosphate in their secretion in the serous fluids.

Authors:  T K Chaudhuri
Journal:  J Nucl Med       Date:  1975-12       Impact factor: 10.057

3.  Distribution of 99mTc-Sn diphosphonate and free 99mTc-pertechnetate in selected soft and hard tissues.

Authors:  E B Silberstein; M D Francis; A J Tofe; C L Slough
Journal:  J Nucl Med       Date:  1975-01       Impact factor: 10.057

4.  Pericardial accumulation of Tc-99m methylene diphosphonate in a case of pericarditis.

Authors:  A Singh; M Usher; L Raphael
Journal:  J Nucl Med       Date:  1977-11       Impact factor: 10.057

5.  Extraosseous noncalcified soft-tissue uptake of 99mTc-polyphosphate.

Authors:  T K Chaudhuri; T K Chaudhuri; H P Gulesserian; J H Christie; N Tonami
Journal:  J Nucl Med       Date:  1974-11       Impact factor: 10.057

6.  A proposed mechanism for 99mTc-labeled polyphosphate and diphosphonate uptake by human breast tissue.

Authors:  G H Schmitt; R A Holmes; A T Isitman; G T Hensley; J D Lewis
Journal:  Radiology       Date:  1974-09       Impact factor: 11.105

7.  Enzymatic inhibition of diphosphonate: a proposed mechanism of tissue uptake.

Authors:  A M Zimmer; A T Isitman; R A Holmes
Journal:  J Nucl Med       Date:  1975-05       Impact factor: 10.057

8.  Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

Authors:  M D Francis; R G Russell; H Fleisch
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

  8 in total
  3 in total

1.  Bone scanning in patients with pleural effusion--experience in 76 cases.

Authors:  S Kosuda; K Yokoyama; I Nishiguchi; E Kunieda; A Kubo; S Hashimoto
Journal:  Ann Nucl Med       Date:  1990-07       Impact factor: 2.668

2.  Accumulation of technetium-99m MDP in pseudomyxoma peritonei.

Authors:  T Kida; F Tsuda; Y Fujita; S Munakata; M Sasaki
Journal:  Ann Nucl Med       Date:  1990-11       Impact factor: 2.668

Review 3.  Diffuse pulmonary uptake of 99mTc bone-imaging agents: case report and survey.

Authors:  J L Coolens; P Devos; M De Roo
Journal:  Eur J Nucl Med       Date:  1985
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.